Tag:
TL011
Latest Headlines
Latest Headlines
Teva pioneering a biosimilar to compete with blockbuster Rituxan
Teva Pharmaceutical is taking aim at Roche's blockbuster Rituxan, confirming reports that it is developing a biosimilar of the monoclonal antibody. Bloomberg reports that Teva appears to be on track
